InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China



BEIJING, March 01, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its next generation TRK inhibitor zurletrectinib (ICP-723) has been granted priority review by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), for the treatment of pediatric patients (aged 2 to 12) with solid tumors harboring NTRK gene fusions. Priority review is one of the key policies introduced by the CDE to accelerate drug approval. Read More



Source link

  • Related Posts

    La reacción devastadora de Messi tras fallar su penal ante Egipto

    IE 11 no es compatible. Para una experiencia óptima, visite nuestro sitio en otro navegador. SIGUIENTE Egipto anota, Hassan pide calma y el banquillo rompe en celebración 01:31 Messi falla…

    A.I.S. Resources Announces Geophysical and Mineral Prospectivity Mapping Results and Defines Multiple High-Priority Drill Targets at New Brunswick Properties

    Forward-looking information is based on management’s current expectations, estimates, projections, assumptions, and beliefs, including assumptions regarding the availability of contractors, weather and operating conditions, receipt of any required permits or…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    5 McDonnell Douglas Engineering Decisions That Became Permanent Features Of Boeing Aircraft After The 1997 Merger

    5 McDonnell Douglas Engineering Decisions That Became Permanent Features Of Boeing Aircraft After The 1997 Merger

    Automated Moderation Is Here to Stay

    Automated Moderation Is Here to Stay

    Gregory Wein, Stylist and Former Abercrombie & Fitch Style Director, Dies at 54

    Gregory Wein, Stylist and Former Abercrombie & Fitch Style Director, Dies at 54

    Taylor Swift wins copyright lawsuit over woman claiming she copied her poems – National

    Taylor Swift wins copyright lawsuit over woman claiming she copied her poems – National

    Midtown Manhattan buildings evacuated after beams found buckling at construction site: Police

    Midtown Manhattan buildings evacuated after beams found buckling at construction site: Police

    La reacción devastadora de Messi tras fallar su penal ante Egipto

    La reacción devastadora de Messi tras fallar su penal ante Egipto